[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mazdutide 9mg by $IVBIY is under review by China's NMPA for obesity, potentially offering a new treatment option. Meanwhile, a preview of multiple myeloma treatments highlights $IVBIY alongside other major pharmaceutical companies.
$ivbiy is a pharmaceutical asset, likely a drug or drug candidate, with recent developments in China and mentions in the context of cancer research.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Month: XXX -XX%
X Months: XXXXXX -XX%
X Year: XXXXXX +162%
1-Year High: XXXXX on 2024-12-13
1-Year Low: X on 2024-11-29
Engagements by network (24h): X: XX
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Month: X -XX%
X Months: XX -XXXX%
X Year: XXX +121%
1-Year High: XX on 2025-03-02
1-Year Low: X on 2024-11-29
Mentions by network (24h): X: X
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $ivbiy in the last XX hours which is no change from in the previous XX hours
Daily Average: X
X Month: X -XX%
X Months: XX -XXXX%
X Year: XX +240%
1-Year High: X on 2025-01-06
1-Year Low: X on 2024-11-29
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$IVBIY as Mazdutide 9mg Supplementary Application Accepted for Review by China's NMPA Potentially Offering a Novel Drug Option for Moderate-to-Severe Obese Population More Info:"
X Link @OzmosiHealth 2025-11-25T14:54Z 2935 followers, XX engagements
"$ACLX $AZN $GILD $REGN $JNJ $LEGN $RHHBY $IVBIY $TAK ASH 2025 preview multiple myeloma focus -Arcellx and AstraZeneca take center stage"
X Link @MarcJacksonLA 2025-11-21T16:25Z 7629 followers, XXX engagements